A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol

Peer Review reports

Original Submission
30 Jan 2017	Submitted	Original manuscript
23 Feb 2017	Reviewed	Reviewer Report - Magdelena Paplinska-Gorya
13 Mar 2017	Reviewed	Reviewer Report - Mark Dransfield
13 Apr 2017	Author responded	Author comments - Pradeesh Sivapalan
Resubmission - Version 2
13 Apr 2017	Submitted	Manuscript version 2
20 Jun 2017	Author responded	Author comments - Pradeesh Sivapalan
Resubmission - Version 3
20 Jun 2017	Submitted	Manuscript version 3
Publishing
8 Aug 2017	Editorially accepted
15 Aug 2017	Article published	10.1186/s12890-017-0458-7

Back to article page